Showing Results for: “Glycemic Index and Diabetes”

The American Diabetes Association® (ADA) will present the 2019 Albert Renold Award to Rudolph L. Leibel, MD. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Leibel will be recognized with this honor during the ADA’s 79th Scientific Sessions, June 7-11, 2019, at the Moscone Convention Center in San Francisco. Dr. Leibel is the Christopher J. Murphy Memorial Professor of Diabetes Research, Professor of Pediatrics and Medicine, Head of the

Top researchers, clinicians and educators will be recognized at the 79th Scientific Sessions for outstanding leadership and work to advance diabetes research, prevention, care and treatment The American Diabetes Association (ADA) is proud to announce the recipients of the ADA’s 2019 National Scientific and Health Care Achievement Awards. Individually and collectively, their exemplary leadership, mentorship and many achievements have advanced the field of diabetes care and improved health outcomes for people living with diabetes. “This year’s National Scientific and Health Care Achievement

Today, the American Diabetes Association® released the 2021 Standards of Medical Care in Diabetes. The 2021 Standards of Care is now live online in Diabetes Care . Based upon the latest scientific diabetes research and clinical trials, the Standards of Care includes new and updated recommendations and guidelines to care for people with diabetes. The Standards of Medical Care in Diabetes—2021 provides the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2, or gestational diabetes; strategies for the prevention or

Consensus report outlines the positive impact of diabetes self-management education and support and the critical need for increased access Seven leading diabetes organizations issued a consensus report today highlighting the value of diabetes self-management education and support (DSMES) services as part of comprehensive diabetes medical care. The report provides compelling evidence for the need for increased utilization of DSMES, four key times that DSMES is most beneficial, and specific recommendations for both clinicians and health systems to increase access to and participation in DSMES

The American Diabetes Association® (ADA) applauds Georgia Governor Brian P. Kemp for signing a bill allowing a broader population of Georgia’s Medicaid beneficiaries to be eligible for a continuous glucose monitor (CGM), a big win for those diagnosed with diabetes who are insulin dependent. CGMs continually monitor blood glucose (blood sugar), giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a lower A1C, an important indicator of glucose management. The

American Diabetes Association Symposium Showcases New Potential Solution for Patients at High-Risk of Kidney Outcomes Today, findings from the landmark FLOW trial, the first dedicated kidney outcomes trial with a GLP-1 (glucagon-like peptide-1) receptor agonist were reported, demonstrating semaglutide significantly reduces the risk of major kidney disease events and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease. New data presented here also highlighted the likely benefits of combined therapy with SGLT2 inhibitors. The results were presented at a symposium